Clinical trial for Localized Malignant Solid Neoplasm
Official title Distance-Based Exercise to Preserve Function and Prevent Disability
ClinicalTrials.gov ID: NCT07059884
What this study is testing
- What it's testing
- This study is testing whether a home‑based exercise program delivered by video can help cancer patients keep their strength and energy. It looks at whether the program is easy to follow and safe.
- Who it's for
- You may be able to join if you have one of the listed cancers and are receiving treatment. You must be able to use a computer or tablet for video calls.
- What's involved
- You will have video sessions with trained staff who guide you through resistance exercises. You will also do unsupervised aerobic workouts at home, following their instructions. The staff will check in with you during the calls.
- Time commitment
- The program lasts for the duration of your treatment, with regular video visits and home workouts. You will need to attend the scheduled video sessions and keep up with the home exercises.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Participants must have histologically confirmed diagnosis of one of the following cancers: anus, bladder...
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Participants must be initiating outpatient cytotoxic chemotherapy for curative intent of at least 10...
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Age 18-64 years
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Patients cannot have metastatic cancer
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Patients cannot have documentation in the medical record of severe cardiovascular, respiratory or...
See the full eligibility criteria
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Participants must have histologically confirmed diagnosis of one of the following cancers: anus, bladder, breast, cervix, colon/rectum, endometrium, esophagus, gallbladder...
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Participants must be initiating outpatient cytotoxic chemotherapy for curative intent of at least 10 weeks duration (with or without concurrent radiation, immunotherapy, or...
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Age 18-64 years
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Patients cannot have metastatic cancer
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Patients cannot have documentation in the medical record of severe cardiovascular, respiratory or musculoskeletal disease or joint problems that preclude moderate physical...
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Patients cannot be pregnant, because this study involves remotely delivered exercise, and cannot be breast-feeding as patients must be receiving cytotoxic chemotherapy, during...
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Patients cannot have documentation in the medical record of current alcohol, substance abuse, or dementia
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Engaged in full time gainful employment of at least 30 hours per week at the time of cancer diagnosis
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Currently no self-report of engagement in competitive sports (e.g.
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Self-reported ability to walk for 6 minutes (use of assistive devices will be allowed)
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Not participating in another weight loss, physical activity, or dietary intervention clinical trial
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Predicted 6MWT distance of 550 meters or less
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Concurrent enrollment in treatment or supportive care trials (other than those focused on weight loss or exercise) is allowed with the permission of the Alliance Executive...
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): Eligibility is restricted to individuals who can comprehend and read English given that participation in the study will require the ability to read intervention materials and...
- REGISTRATION ELIGIBILITY CRITERIA (STEP 1): The trial is unable to accommodate the needs of deaf or blind participants as the study relies on language and visualization of exercise through telehealth sessions
- CLINICAL STAKEHOLDER ELIGIBILITY CRITERIA: Clinicians and research staff from enrolling sites who meet following criterion will be deemed eligible to participate as a clinical stakeholder: \ Providing clinical care for...
- CLINICAL STAKEHOLDER ELIGIBILITY CRITERIA: Ability to speak and understand English
The study team makes the final eligibility decision.
Where it is enrolling
- Dublin, California, United States
- Fremont, California, United States
- Fresno, California, United States
- Modesto, California, United States
- Oakland, California, United States
- Sacramento, California, United States
- San Francisco, California, United States
- San Jose, California, United States
- San Rafael, California, United States
- Santa Clara, California, United States
- Santa Rosa, California, United States
- Vallejo, California, United States
- Walnut Creek, California, United States
- Boston, Massachusetts, United States
- Kernersville, North Carolina, United States
- Mount Airy, North Carolina, United States
- Winston-Salem, North Carolina, United States
- Butler, Pennsylvania, United States
- Cranberry Township, Pennsylvania, United States
- Indiana, Pennsylvania, United States
+ 6 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Dublin, California, United States; Fremont, California, United States; Fresno, California, United States; Modesto, California, United States; Oakland, California, United States; Sacramento, California, United States and 20 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.